8
Oct
2024

Shenzhen Mellow Hope Pharm Industrial Co., Ltd.

Exhibitor at CPHI Milan 2024 stand 16A58, Finished Dosage Formulations
About Us

Shenzhen Mellow Hope Pharm Industrial Co., Ltd, specializing in exporting biological products, has grown to be one of the biggest exporters of vaccines and bio-pharmaceuticals in China after ten-year of unremitting efforts.
Mellow Hope cooperates with many well-known biological institutes and companies in the Research & Development of new products and introductions of new technologies, as well as conducts registrations, carries out clinical trials, promotes and markets products around the world. In order to meet different market...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 1
    Certificates
  • 100 - 249
    Employees
Company types
Biopharmaceutical company
Distributor/Import Export
Manufacturer/Innovator
Primary activities
Biopharmaceutical
Finished Formulation products Distributor/Buyer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16A58, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Recombinant Human Basic Fibroblast Growth Factor for External Use

    Product Recombinant Human Basic Fibroblast Growth Factor for External Use

    [Dosage form]: Freeze-dried powder [Specification]: 20,000IU/vial, 35,000IU/vial, 70,000IU/vial, 300,000IU/vial 
    [Indication]: Promote wound healing and can be used for chronic wounds (including chronic granulation wounds, ulcers and bedsores, etc.), fresh wounds (including trauma, surgical ...
  • Adalimumab Injection

    Product Adalimumab Injection

    [Dosage form]: Liquid for injection [Specification]: 40mg/0.8ml, pre-filled syringe [Indication]: Used to treat many inflammatory conditions in adults, such as Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Crohn’s Disease, Ulcerative Colitis, Pl...
  • Meningococcal Polysaccharide Vaccine (Group A/C/Y/W135)

    Product Meningococcal Polysaccharide Vaccine (Group A/C/Y/W135)

    [Dosage Form]: Freeze-dried powder for Injection [Indication]: The vaccine is indicated for active immunization against invasive meningococcal disease caused by Neisseria meningitis group A, group C, group Y and group W135. 
    [Specification]: Each 0.5 ml dose of reconstituted vaccine contains 5...
  • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine

    Product 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine

    [Dosage form]: Suspension for injection [Specification]: 0.5 ml/dose 
    [Indication]: Protect infants over 2 months, young children, and adults against disease caused by the bacterium Streptococcus pneumonia. 
    [Administration]: Intramuscular injection 
    [Storage temperature (℃)]: ...